William K Evans

Summary

Affiliation: Cancer Care Ontario
Country: Canada

Publications

  1. ncbi request reprint Practitioner feedback on lung cancer practice guidelines in Ontario
    William K Evans
    Juravinski Cancer Center, Hamilton Health Sciences, Hamilton, Ontario, Canada
    J Thorac Oncol 1:10-8. 2006
  2. ncbi request reprint Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline
    Susanna Cheng
    Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada
    J Thorac Oncol 2:348-54. 2007
  3. ncbi request reprint Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer
    George Dranitsaris
    Cancer Care Ontario, Toronto, Canada
    Curr Opin Oncol 14:375-83. 2002
  4. ncbi request reprint Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review
    Ron Feld
    Princess Margaret Hospital, Toronto, Ontario, Canada
    J Thorac Oncol 1:367-76. 2006
  5. ncbi request reprint Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review
    Naveed Alam
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Thorac Surg 81:1926-36. 2006
  6. ncbi request reprint Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs
    William K Evans
    Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7
    Chronic Dis Can 23:152-6. 2002
  7. ncbi request reprint Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis
    William K Evans
    Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7
    Chronic Dis Can 24:102-7. 2003
  8. doi request reprint Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs
    Scott R Berry
    Sunnybrook Odette Cancer Center, 2075 Bayview Ave, Toronto, Ontario, Canada
    J Clin Oncol 28:4149-53. 2010
  9. ncbi request reprint Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, Natio
    Raymond Ng
    Department of Hematology and Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 25:2256-61. 2007
  10. pmc Public engagement in setting priorities in health care
    Rebecca A Bruni
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    CMAJ 179:15-8. 2008

Detail Information

Publications32

  1. ncbi request reprint Practitioner feedback on lung cancer practice guidelines in Ontario
    William K Evans
    Juravinski Cancer Center, Hamilton Health Sciences, Hamilton, Ontario, Canada
    J Thorac Oncol 1:10-8. 2006
    ..In this study, the PF was reviewed to assess the frequency of response to the surveys, the respondents' characteristics, the nature of the feedback, and the intention to adopt the guideline in practice...
  2. ncbi request reprint Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline
    Susanna Cheng
    Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada
    J Thorac Oncol 2:348-54. 2007
    ..This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cell lung cancer (SCLC)...
  3. ncbi request reprint Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer
    George Dranitsaris
    Cancer Care Ontario, Toronto, Canada
    Curr Opin Oncol 14:375-83. 2002
    ..This article reviews the pharmacoeconomic literature to provide guidance on the cost-effective use of chemotherapy in the treatment of advanced nonsmall-cell lung cancer...
  4. ncbi request reprint Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review
    Ron Feld
    Princess Margaret Hospital, Toronto, Ontario, Canada
    J Thorac Oncol 1:367-76. 2006
    ..In this systematic review, we evaluated the role of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of patients with advanced NSCLC...
  5. ncbi request reprint Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review
    Naveed Alam
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Thorac Surg 81:1926-36. 2006
    ..To date the trials restricted to stage IB or II disease have obtained the greatest survival benefits with postoperative platinum-based chemotherapy. The evidence does not support the use of postoperative radiotherapy with chemotherapy...
  6. ncbi request reprint Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs
    William K Evans
    Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7
    Chronic Dis Can 23:152-6. 2002
    ..7 million. These intravenous drugs can now be accessed through nine Regional Cancer Centres, the province's only cancer hospital (Princess Margaret Hospital) and 80 community hospitals and will directly benefit more than 8,700 patients...
  7. ncbi request reprint Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis
    William K Evans
    Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7
    Chronic Dis Can 24:102-7. 2003
    ..These recommendations are currently guiding priority setting with regard to trials for economic evaluation in NCIC trials. Examples of how these recommendations have been applied to actual trials are presented...
  8. doi request reprint Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs
    Scott R Berry
    Sunnybrook Odette Cancer Center, 2075 Bayview Ave, Toronto, Ontario, Canada
    J Clin Oncol 28:4149-53. 2010
    ..We compared their attitudes regarding the costs and cost-effectiveness of medications and related health policy...
  9. ncbi request reprint Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, Natio
    Raymond Ng
    Department of Hematology and Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 25:2256-61. 2007
    ..This cost-effectiveness analysis of adjuvant chemotherapy from the perspective of Canada's public health care system was undertaken based on the JBR.10 study population...
  10. pmc Public engagement in setting priorities in health care
    Rebecca A Bruni
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    CMAJ 179:15-8. 2008
  11. ncbi request reprint Influence of sex on toxicity and treatment outcome in small-cell lung cancer
    Simron Singh
    Division of Medical Oncology, Department of Medicine, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 23:850-6. 2005
    ..Studies have shown that women with other tumor types experience greater treatment toxicity, but there have been few studies of sex-related toxicity in SCLC...
  12. ncbi request reprint End-of-life home care utilization and costs in patients with advanced colorectal cancer
    Nicole Mittmann
    Health Outcomes and PharmacoEconomic HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Email
    J Community Support Oncol 12:92-8. 2014
    ..To determine overall utilization and costs associated with home care services in Ontario, Canada by linking a home care database to a stage IV colorectal cancer cohort...
  13. ncbi request reprint Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer
    John J You
    Departments of Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Departments of Radiation Oncology and Surgery, University of Toronto, Ontario, Canada Department of Radiology, McMaster University, and Integrated Department of Nuclear Medicine and Molecular Imaging, Hamilton, Ontario, Canada Department of Nuclear Medicine, Lebanon VA Medical Center, Lebanon, Pennsylvania and Department of Oncology, McMaster University, and Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada
    J Thorac Oncol 8:1563-9. 2013
    ..18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) may play an important role in staging patients with potentially resectable esophageal cancer but its impact on clinical management remains unclear...
  14. ncbi request reprint Evaluation of diagnostic assessment units in oncology: a systematic review
    Anna Gagliardi
    Cancer Care Ontario, 620 University Ave, Toronto, ON M5G 2L7 Canada
    J Clin Oncol 22:1126-35. 2004
    ..This systematic review was undertaken to identify clinical and economic evaluations of diagnostic assessment units for cancer; summarize measures used to evaluate such programs; and discuss the strengths and weaknesses of these evaluations...
  15. ncbi request reprint Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review
    Naveed Alam
    Peter MacCallum Cancer Center, Melbourne, Australia
    Crit Rev Oncol Hematol 58:146-55. 2006
    ..To conduct a systematic review and to evaluate the impact of postoperative adjuvant chemotherapy on the survival of patients with completely resected non-small cell lung cancer...
  16. ncbi request reprint Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline
    Gordon Okawara
    Hamilton Regional Cancer Centre, 699 Concession Street, Hamilton, Ont, Canada L8V 5C2
    Lung Cancer 44:1-11. 2004
    ..Recommendations: Postoperative radiation therapy following complete resection of stage II non-small cell lung cancer is not recommended. No definitive recommendation can be made for stage IIIA disease...
  17. ncbi request reprint Management of unresected stage III non-small cell lung cancer: a systematic review
    Gordon Okawara
    Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada
    J Thorac Oncol 1:377-93. 2006
    ..To conduct a systematic review to determine the most effective therapy for patients with unresected stage III non-small cell lung cancer...
  18. ncbi request reprint Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline
    Quincy Chu
    Department of Medical Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alt, Canada
    Lung Cancer 50:355-74. 2005
    ....
  19. ncbi request reprint Photodynamic therapy in nonsmall cell lung cancer: a systematic review
    Donna E Maziak
    University of Ottawa, Ottawa Hospital General Campus, Ontario, Canada
    Ann Thorac Surg 77:1484-91. 2004
    ..The safety and effectiveness of photodynamic therapy compared with other treatment modalities remains undefined. Serious adverse effects can occur; therefore, the suitability of patients for this treatment should be carefully assessed...
  20. ncbi request reprint Job stress and job satisfaction of cancer care workers
    Eva Grunfeld
    Ottawa Regional Cancer Centre, Ottawa Health Research Institute, Ottawa, Ontario Canada K1H 1C4
    Psychooncology 14:61-9. 2005
    ..There is an increasing demand for oncology care as a result of a number of trends. In combination with ongoing changes to the health-care system, these trends have an impact on the workplace environment of systemic therapy personnel...
  21. ncbi request reprint Lifetime costs of colon and rectal cancer management in Canada
    Jean Maroun
    Ottawa Regional Cancer Centre, 503 Smyth Road, Ottawa, Ontario, Canada K1H 1C4
    Chronic Dis Can 24:91-101. 2003
    ..Similarly, terminal care might be delivered more efficiently in the home environment or in palliative care units...
  22. ncbi request reprint Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer
    Scott A Laurie
    Ottowa Regional Cancer Centre, Ottawa, ON, Canada
    Lung Cancer 43:223-40. 2004
    ....
  23. ncbi request reprint 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review
    Yee C Ung
    Odette Cancer Centre and University of Toronto, Toronto, ON, Canada
    J Natl Cancer Inst 99:1753-67. 2007
    ..Further trials are necessary to establish the clinical utility of PET as part of the standard preoperative assessment of early-stage lung cancer...
  24. ncbi request reprint Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline
    Katherine M W Pisters
    M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 25:5506-18. 2007
    ..To determine the role of adjuvant chemotherapy and radiation therapy in patients with completely resected stage IA-IIIA non-small-cell lung cancer (NSCLC)...
  25. ncbi request reprint The role of knowledge translation for cancer control in Canada
    Eva Grunfeld
    Cancer Care Nova Scotia, Halifax, Nova Scotia, Canada
    Chronic Dis Can 25:1-6. 2004
    ..It is an ideal time for the Canadian Strategy for Cancer Control and other Canadian cancer control initiatives to determine where they will locate knowledge translation in relation to their objectives...
  26. ncbi request reprint The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline
    Peter Ellis
    McMaster University at Hamilton Health Sciences and Juravinski Cancer Centre, Hamilton, Ontario, Canada
    J Thorac Oncol 1:591-601. 2006
    ....
  27. ncbi request reprint Treatment of recurrent small cell lung cancer
    Angela M Davies
    University of California at Davis Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA
    Hematol Oncol Clin North Am 18:387-416. 2004
  28. ncbi request reprint Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary
    Donna E Maziak
    University of Ottawa, Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ont, Canada K1H 8L6
    Lung Cancer 48:157-69. 2005
    ..External feedback was obtained from Ontario clinicians, and the provincial Lung Cancer Disease Site Group approved the review...
  29. ncbi request reprint The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer
    George Dranitsaris
    Consultant Pharmacist, Cancer Care Ontario, Ontario M5G 2L7, Canada
    J Eval Clin Pract 11:350-6. 2005
    ..A provincial drug database was used to determine the impact that these new policies had on the rate of vinorelbine and gemcitabine uptake within the CCO new drug funding programme...
  30. ncbi request reprint The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review
    Yee C Ung
    Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, Canada
    Brachytherapy 5:189-202. 2006
    ..This review addresses the role of high-dose-rate endobronchial brachytherapy (HDREB) for symptom palliation in patients with non-small-cell lung cancer...
  31. ncbi request reprint The role of radiation therapy in malignant pleural mesothelioma: a systematic review
    Yee C Ung
    Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, Canada
    Radiother Oncol 80:13-8. 2006
    ..Radiation therapy may offer patients presenting with malignant pleural mesothelioma (MPM) symptom palliation and improvements in quality of life. This systematic review will address the role of radiation therapy in the management of MPM...
  32. ncbi request reprint Better knowledge translation for effective cancer control: a priority for action
    Eva Grunfeld
    Cancer Care Nova Scotia, Dalhousie University, 1278 Tower Road, Halifax, Nova Scotia, Canada B3H 2Y9
    Cancer Causes Control 15:503-10. 2004
    ..Adding a knowledge translation component to national cancer control programs can help ensure that even small efforts directed at cancer control can have maximum impact...